Head-to-head trial shows Mounjaro is more effective than Wegovy for weight loss The first direct comparison between two leading weight-loss medications has found that Mounjaro (tirzepatide) helps people lose more weight than Wegovy (semaglutide)
Beyond the number on the scale, semaglutide reduces visceral fat (belly fat around organs), which is linked to heart disease, type 2 diabetes, and metabolic syndrome
This mechanism contributes to improved glycaemic control and weight reduction, as demonstrated in clinical trials
Some people using semaglutide (Ozempic, others) have noticed sagging skin in the buttocks after losing weight, calling it Ozempic butt. While lifestyle modifications may help prevent this side effect, a doctor may recommend surgery to treat excess, sagging skin
Keeping your skin well-moisturized is crucial
Practical Usage Tips Use for a defined period (e.g., 8-12 weeks) and evaluate: Are you seeing desired results